Additional Relevant Details Evoke Pharma provided an update on enrollment of its ongoing Phase 3 clinical trial of EVK-001, its patented nasal delivery formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Additionally, the Company has amended a covenant associated with timing of Phase 3 data results under its $4.5 million loan and security agreement (the credit facility) with Pacific Western Bank (as successor to Square 1 Bank).